Ranibizumab Is a Potential Prophylaxis for Proliferative Vitreoretinopathy, a Nonangiogenic Blinding Disease-Reference-Cited by-同舟云学术

Ranibizumab Is a Potential Prophylaxis for Proliferative Vitreoretinopathy, a Nonangiogenic Blinding Disease

Published:2013-05 Issue:5 Volume:182 Page:1659-1670
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Pennock Steven,Kim David,Mukai Shizuo,Kuhnle Matthew,Chun Dal W.,Matsubara Joanne,Cui Jing,Ma Patrick,Maberley David,Samad Arif,Van Geest Robert J.,Oberstein Sarit L.,Schlingemann Reinier O.,Kazlauskas Andrius

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference62 articles.

1. Han D: Proliferative Vitreoretinopathy. In: Albert D, JW M, DT A, BA B editor. Philadelphia, PA: Elsevier Saunders; 2008;p. 2315–2324.

2. Proliferative Retinopathy;Michels,1990

3. Proliferative vitreoretinopathy: an overview;Pastor;Surv Ophthalmol,1998

4. Resources involved in managing retinal detachment complicated by proliferative vitreoretinopathy;Patel;Retina,2004

5. Proliferative vitreoretinopathy: developments in pathogenesis and treatment;Asaria;Compr Ophthalmol Update,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy;Ophthalmology;2024-08

2. Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy;Journal of Diabetes Research;2024-01

3. Challenges in proliferative vitreoretinopathy: is biological therapy a solution?;Expert Opinion on Biological Therapy;2023-08-18

4. Proliferative Vitreoretinopathy: A Reappraisal;Journal of Clinical Medicine;2023-08-14

5. Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment;Journal of Clinical Medicine;2023-02-05